Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 47, Issue 1, 2015, Pages 243-252

  Van Harten, Argonde C ^a,b   Mulders, Joyce ^b   Scheltens, Philip ^a,b   Van Der Flier, Wiesje M ^a,b   Oudejans, Cees B M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Biomarkers; Crebrospinal fluid; MicroRNAs

Indexed keywords

BIOLOGICAL MARKER; MEGESTROL ACETATE; MICRORNA; MESSENGER RNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL MODEL; STRATIFICATION; STUDENT T TEST; BIBLIOGRAPHIC DATABASE; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; STATISTICS AND NUMERICAL DATA;

AGED; ALZHEIMER DISEASE; BIOMARKERS; CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RNA, MESSENGER;

EID: 84940927979     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140075     Document Type: Article

References (50)

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
3. Hardy J (1997) The Alzheimer family of diseases: Many etiologies, one pathogenesis? Proc Natl Acad Sci U S A 94, 2095-2097.
4. Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: A critical reappraisal. J Neurochem 110, 1129-1134.
5. Querfurth HW, LaFerla FM (2010) Mechanisms of disease: Alzheimer's disease. N Engl J Med 362, 329-344.
6. Lau PW, MacRae IJ (2009) The molecular machines that mediate microRNA maturation. J Cell Mol Med 13, 54-60.
7. Rana TM (2007) Illuminating the silence: Understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8, 23-36.
8. Boissonneault V, Plante I, Rivest S, Provost P (2009) MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284, 1971-1981.
9. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G 3rd, Kenny PJ, Wahlestedt C (2008) Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 14, 723-730.
10. Fang M, Wang J, Zhang X, Geng Y, Hu Z, Rudd JA, Ling S, Chen W, Han S (2012) The miR-124 regulates the expression of BACE1/-secretase correlated with cell death in Alzheimer's disease. Toxicol Lett 209, 94-105.
11. Hébert SS, Horré K, Nicolaï L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 105, 6415-6420.
12. Hébert SS, Horré K, Nicolaï L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B (2009) MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33, 422-428.
13. Liang C, Zhu H, Xu Y, Huang L, Ma C, Deng W, Liu Y, Qin C (2012) MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res 1455, 103-113.
14. Long JM, Lahiri DK (2011) MicroRNA-101 downregulates Alzheimer's amyloid- precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404, 889-895.
15. Niwa R, Zhou F, Li C, Slack FJ (2008) The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Dev Biol 315, 418-425.
16. Patel N, Hoang D, Miller N, Ansaloni S, Huang Q, Rogers JT, Lee JC, Saunders AJ (2008) MicroRNAs can regulate human APP levels. Mol Neurodegener 3, 10-10.
17. Smith P, Al Hashimi A, Girard J, Delay C,Hébert SS (2011) In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem 116, 240-247.
18. Vilardo E, Barbato C, Ciotti MT, Cogoni C, Ruberti F (2010) MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 285, 18344-18351.
19. Wang X, Su B, Fujioka H, ZhuX(2008) Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol 173, 470-482.
20. Cohen JE, Lee PR, Chen S, Li W, Fields RD (2011) MicroRNAregulation of homeostatic synaptic plasticity. Proc Natl Acad Sci U S A 108, 11650-11655.
21. Hansen KF, Sakamoto K, Wayman GA, Impey S, Obrietan K (2010) Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. PLoS One 5, e15497.
22. Hébert SS,DeStrooperB(2009) Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 32, 199-206.
23. Jennewein C, von Knethen A, Schmid T, Brüne B (2010) MicroRNA-27b contributes to lipopolysaccharidemediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 285, 11846-11853.
24. Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaBsensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283, 31315-31322.
25. Lukiw WJ (2013) Antagonism of NF-κB-up-regulated micro RNAs (miRNAs) in sporadic Alzheimer's disease (AD)-anti- NF-κ B vs. anti-miRNA strategies. Front Genet 4, 77.
26. Sethi P, Lukiw WJ (2009) Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 459, 100-104.
27. Cogswell JP1, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM,Roses AD, RichardsCA(2008) Identification of miRNAchanges in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14, 27-41.
28. Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus [Internet]. Neuroreport 18, 297-300.
29. Nelson PT, Wang WX (2010) MiR-107 is reduced in Alzheimer's disease brain neocortex: Validation study. J Alzheimers Dis 21, 75-79.
30. Shioya M, Obayashi S, Tabunoki H, Arima K, Saito Y, Ishida T, Satoh J (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 36, 320-330.
31. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28, 1213-1223.
32. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT (2011) Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: White matter versus gray matter. Acta Neuropathol 121, 193-205.
33. Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T,Götz J (2010) Neuronal microRNAderegulation in response to Alzheimer's disease amyloid-beta. PLoS One 5, e11070.
34. Yao J, Hennessey T, Flynt A, Lai E, Beal MF, Lin MT (2010) MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One 5, e15546.
35. van Harten A, Mulders J,Ç evik C,Kester M, Scheltens P, Flier W, Oudejans C (2011) MicroRNA analysis in the spinal fluid of Alzheimer patients: A methodological feasibility study. In: Circulating Nucleic Acids in Plasma and Serum, Gahan PB, ed. Springer Science+Business Media B.V., Netherlands, pp. 275-282.
36. Lehmann SM, Krüger C, Park B, Derkow K, Rosenberger K, Baumgart J, Trimbuch T, Eom G, Hinz M, Kaul D, Habbel P, Kälin R, Franzoni E, Rybak A, Nguyen D, Veh R, Ninnemann O, Peters O, Nitsch R, Heppner FL, Golenbock D, Schott E, Ploegh HL, Wulczyn FG, Lehnardt S (2012) An unconventional role for miRNA: Let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15, 827-835.
37. Sala Frigerio C, Lau P, Salta E, Tournoy J, Bossers K, Vandenberghe R,Wallin A, Bjerke M, Zetterberg H, Blennow K, De Strooper B (2013) Reduced expression of hsa-miR-27a- 3p in CSF of patients with Alzheimer disease. Neurology 81, 2103-2106.
38. Müller M, Kuiperij HB, Claassen JA, Küsters B, Verbeek MM (2014) MicroRNAs in Alzheimer's disease: Differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35, 152-158.
39. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
40. Mulder C, Verwey A, van der Flier M, Bouwman H, Kok A, van Elk J, Scheltens P, Blankenstein A (2010) Amyloid- (1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 56, 248-253.
41. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, Vandesompele J (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10, R64-R64.
42. Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zöllner H, Schmiegel W, Hahn S, Schroers R (2012) Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro Oncol 14, 29-33.
43. Jeanmougin M, de Reynies A, Marisa L, Paccard C, Nuel G, Guedj M (2010) Should we abandon the t-test in the analysis of gene expression microarray data:Acomparison of variance modeling strategies. PLoS One 5, e12336.
44. McAlexander MA, Phillips MJ, Witwer KW (2013) Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid. Front Genet 4, 83.
45. Inukai S, de Lencastre A, Turner M, Slack F (2012) Novel microRNAs differentially expressed during aging in the mouse brain. PLoS One 7, e40028.
46. Jung HJ, Suh Y (2012) MicroRNA in aging: From discovery to biology. Curr Genomics 13, 548-557.
47. Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2012) microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3, 365-373.
48. Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T,Weiner HL (2013) Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73, 729-740.
49. Smith PY, Delay C, Girard J, Papon MA, Planel E, Sergeant N, Buée L, Hébert SS (2011) MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 20, 4016-4024.
50. Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stähler C, Lang CJ, Meder B, Bartfai T, Meese E, Keller A (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14, R78.